why choose us

First received: October 10, 2023

Clinical Trial: A Phase I Study of LY3502970 in Healthy Participants

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Healthy

Study Type: INTERVENTIONAL


Official Title: A Single-Group, Open-Label, Single-Period, Phase 1 Study to Determine the Absolute Bioavailability of LY3502970 in Healthy Participants

Brief Summary: The main purpose of this study is to evaluate how much of the study drug (LY3502970) and the radioactive substance 14C incorporated LY3502970 gets into the bloodstream, how its broken down, and how long it takes the body to get rid of it.The study will last up to approximately 9 weeks for each participant.

Read more